Plasma NOV/CCN3 Levels Are Closely Associated with Obesity in Patients with Metabolic Disorders

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Pakradouni, Jihane ^a,b,c   Le Goff, Wilfried ^b,d,f   Calmel, Claire ^a,b   Antoine, Bénédicte ^a,b   Villard, Elise ^b,d,f   Frisdal, Eric ^b,d,f   Abifadel, Marianne ^g,h   Tordjman, Joan ^b,e   Poitou, Christine ^b,e   Bonnefont Rousselot, Dominique ^d   Bittar, Randa ^d   Bruckert, Eric ^d,f   Clément, Karine ^b,e,f   Fève, Bruno ^a,b   Martinerie, Cécile ^a,b   Guérin, Maryse ^b,d,f  

^a HÔPITAL SAINT ANTOINE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c Paris Santé Cochin Incubator   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e CENTRE DE RECHERCHE DES CORDELIERS   (France)

^f IHU ICAN   (France)

^g BICHAT HOSPITAL   (France)

^h SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BARIATRIC SURGERY; BLOOD ANALYSIS; BODY MASS; CARDIOVASCULAR RISK; CELL CULTURE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERLIPIDEMIA; LIPID DIET; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; RODENT; ROUX Y ANASTOMOSIS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; AGED; ANIMALS; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; DIET, HIGH-FAT; FEMALE; HUMANS; LIPID METABOLISM; MALE; METABOLIC DISEASES; MICE; MIDDLE AGED; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; OBESITY; RISK FACTORS;

MUS; RODENTIA;

EID: 84879956984     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066788     Document Type: Article

References (40)

1. Joliot V, Martinerie C, Dambrine G, Plassiart G, Brisac M, et al. (1992) Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol 12: 10-21.
2. Chen CC, Lau LF, (2009) Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 41: 771-783.
3. Kular L, Pakradouni J, Kitabgi P, Laurent M, Martinerie C, (2011) The CCN family: A new class of inflammation modulators? Biochimie 93: 377-388 Epub 2010 Dec 2.
4. Burren CP, Wilson EM, Hwa V, Oh Y, Rosenfeld RG, (1999) Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP Superfamily. J Clin Endocrinol Metab 84: 1096-1103.
5. Martinerie C, Gicquel C, Louvel A, Laurent M, Schofield P, et al. (2001) Altered expression of NovH is asociated with human adrenocortical tumorigenesis. JCEM 86: 3929-3940.
6. Su BY, Cai WQ, Zhang CG, Martinez V, Lombet A, et al. (2001) The expression of ccn3 (nov) RNA and protein in the rat central nervous system is developmentally regulated. Mol Pathol 54: 184-91.
7. Thibout H, Martinerie C, Creminon C, Godeau F, Boudou P, et al. (2003) Characterization of human NOV in biological fluids: an enzyme immunoassay for the quantification of human NOV in sera from patients with diseases of the adrenal gland and of the nervous system. J Clin Endocrinol Metab. 88: 327-36.
8. Doghman M, Arhatte M, Thibout H, Rodrigues G, De Moura J, et al. (2007) Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors. J Clin Endocrinol Metab 92: 3253-60.
9. Chevalier G, Yeger H, Martinerie C, Laurent M, Alami J, et al. (1998) nov H: Differential expression in developing kidney and in Wilms' tumors. Am J Pathol 152: 1563-1575.
10. Manara MC, Perbal B, Benini S, Strammiello R, Cerisano V, et al. (2002) The expression of ccn3(nov) gene in musculoskeletal tumors. Am J Pathol. 160: 849-859.
11. McCallum L, Lu W, Price S, Lazar N, Perbal B, et al. (2009) CCN3: a key growth regulator in Chronic Myeloid Leukaemia. J Cell Commun Signal 3: 115-24.
12. Niu Z, Ito M, Awakura Y, Takahashi T, Nakamura E, et al. (2005) The expression of NOV and WT1 in renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis. J Urol 174: 1460-2.
13. Fukunaga-Kalabis M, Martinez G, Telson SM, Liu ZJ, Balint K, et al. (2008) Downregulation of CCN3 expression as a potential mechanism for melanoma progression. Oncogene 27: 2552-60.
14. Benini S, Perbal B, Zambelli D, Colombo MP, Manara MC, et al. (2005) In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Oncogene 24: 4349-61.
15. Heath E, Tahri D, Andermarcher E, Schofield P, Fleming S, et al. (2008) Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene. BMC Dev Biol 8: 18-25.
16. Rydziel S, Stadmeyer L, Zanotti S, Durant D, Smerdel-Ramoya A, et al. (2007) Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia. J Biol Chem 282: 19762-72.
17. Shimoyama T, Hiraoka S, Takemoto M, Koshizaka M, Tokuyama H, et al. (2010) CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration. Arterioscler Thromb Vasc Biol 30: 675-82.
18. Kimura A, Martin C, Robinson GW, Simone JM, Chen W, et al. (2010) The gene encoding the hematopoietic stem cell regulator CCN3/NOV is under direct cytokine control through the transcription factors STAT5A/B. J Biol Chem 285: 32704-9.
19. Lin Z, Natesan V, Shi H, Hamik A, Kawanami D, et al. (2010) A novel role of CCN3 in regulating endothelial inflammation. J Cell Commun Signal 4: 141-53.
20. Le Dreau G, Kular L, Nicot AB, Calmel C, Melik-Parsadaniantz S, et al. (2010) NOV/CCN3 upregulates CCL2 and CXCL1 expression in astrocytes through beta1 and beta5 integrins. Glia 58: 1510-1521.
21. Libby P, Okamoto Y, Rocha VZ, Folco E, (2010) Inflammation in atherosclerosis: transition from theory to practice. Circ J 74: 213-20.
22. Breland UM, Halvorsen B, Hol J, Oie E, Paulsson-Berne G, et al. (2008) A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins. Arterioscler Thromb Vasc Biol 28: 1005-11.
23. Poitou C, Dalmas E, Renovato M, Benhamo V, Hajduch F, et al. (2011) CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis. Arterioscler Thromb Vasc Biol 31: 2322-30.
24. Larrede S, Quinn CM, Jessup W, Frisdal E, Olivier M, et al. (2009) Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent. Arterioscler Thromb Vasc Biol 29: 1930-6.
25. Calhabeu F, Lafont J, Le Dreau G, Laurent M, Kazazian C, et al. (2006) NOV/CCN3 impairs muscle cell commitment and differentiation. Exp Cell Res 1876-1889.
26. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
27. Vendrell JA, Magnino F, Danis E, Duchesne MJ, Pinloche S, et al. (2004) Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J Mol Endocrinol 32: 397-414.
28. Couillard C, Mauriege P, Prud'homme D, Nadeau A, Tremblay A, et al. (1997) Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease. Diabetologia 40: 1178-84.
29. Hellstrom L, Wahrenberg H, Hruska K, Reynisdottir S, Arner P, (2000) Mechanisms behind gender differences in circulating leptin levels. J Intern Med 247: 457-62.
30. Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE, (2008) Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. J Cardiovasc Pharmacol 51: 331-51.
31. Bouloumie A, Curat CA, Sengenes C, Lolmede K, Miranville A, et al. (2005) Role of macrophage tissue infiltration in metabolic diseases. Curr Opin Clin Nutr Metab Care 8: 347-54.
32. Bruun JM, Lihn AS, Pedersen SB, Richelsen B, (2005) Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 90: 2282-9.
33. Christiansen T, Richelsen B, Bruun JM, (2005) Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond) 29: 146-50.
34. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM, (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95: 2409-15.
35. Samad F, Yamamoto K, Pandey M, Loskutoff DJ, (1997) Elevated expression of transforming growth factor-beta in adipose tissue from obese mice. Mol Med 3: 37-48.
36. Braunersreuther V, Zernecke A, Arnaud C, Liehn EA, Steffens S, et al. (2007) Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler Thromb Vasc Biol 27: 373-9.
37. Inoue S, Egashira K, Ni W, Kitamoto S, Usui M, et al. (2002) Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation 106: 2700-6.
38. Dalmas E, Rouault C, Abdennour M, Rovere C, Rizkalla S, et al. (2011) Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction. Am J Clin Nutr 94: 450-8.
39. Poitou C, Divoux A, Faty A, Tordjman J, Hugol D, et al. (2009) Role of serum amyloid a in adipocyte-macrophage cross talk and adipocyte cholesterol efflux. J Clin Endocrinol Metab 94: 1810-7.
40. Divoux A, Clement K, (2011) Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue. Obes Rev 12: e494-503.